A Sad Day for Science at the FDA
- 22 September 2005
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (12) , 1197-1199
- https://doi.org/10.1056/nejmp058222
Abstract
The Food and Drug Administration (FDA) has again postponed issuing a decision about making emergency contraception available to women without a prescription. This decision — or nondecision — deserves serious scrutiny, since it appears to reflect political meddling in the drug-approval process.Emergency contraception in the form of Plan B has been available by prescription in the United States since 1999, but its manufacturer, Barr Laboratories, has proposed that it be sold over the counter. Plan B consists of two 0.75-mg levonorgestrel tablets to be taken 12 hours apart as soon as possible, and within 72 hours, after an act . . .Keywords
This publication has 0 references indexed in Scilit: